Precision Neuroscience
Precision Neuroscience Raises $102M Series C | Brain-Computer Interface
Precision Neuroscience Closes $102M for BCI Development
Precision Neuroscience, developing minimally invasive brain-computer interface technology, has raised $102 million in Series C funding.
The round was led by B Capital with participation from Steadview Capital and Alumni Ventures.
Key Highlights
- Total funding to date: $155 million
- Minimally invasive neural implant approach
- Founded by Neuralink co-founder
Company Overview
Precision Neuroscience is developing minimally invasive brain-computer interface technology to restore function for patients with neurological conditions, competing with Neuralink in the emerging BCI market.
Company Info
Investors (3)
Share
Related Reports
Wabi Raises $55M at $1.25B Valuation in IVP-Led Funding
Wabi announced $55 million in funding led by IVP at a $1.25 billion valuation, which it said will support continued product development and expansion.
StimCardio Raises $30M Series A for Wearable AF Therapeutic
StimCardio announced the closing of an oversubscribed $30 million Series A led by Metis Medtech, expected to fund the company through its planned NeuroPulse 2 pivotal study and preparation for an FDA De Novo submission.
Casap Raises $56M Series B for AI Agents in Financial Services
Casap raised a $56 million Series B led by Base10 Partners, with Experian and Synchrony participating, to advance its AI agent platform for financial services.
Turn your sales ideas into reality today
Pick a plan and go live today. Change or cancel any time.
Get started